Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Vaccine entities : Sanofi save search
Pneumococcal Vaccine Market, 41% of Growth to Originate from North America, Technavio
Published: 2024-04-16 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 0.63% -2.18% 1.4K
|
Health Technology
|
| O: 0.12%
H: 0.51%
C: 0.51%
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: 1.0%
H: 0.19%
C: -0.47%
pneumococcal vaccine growth
Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trials
Published: 2024-03-27 (Crawled : 12:00) - biospace.com/
SNYNF | News | $92.7 0.63% -2.18% 1.4K
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: 0.0%
MRNA | News S | $103.44 -0.34% -0.33% 1.5M
|
Health Technology
|
| O: 2.02%
H: 1.41%
C: 0.92%
vaccine trials
World Vaccine Market Research Report 2023-2024 and 2030 - Increasing Consumer Awareness Towards Immunization Fueling Growth Amid Growing Prevalence of Infectious Diseases
Published: 2024-03-12 (Crawled : 02:00) - prnewswire.com
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
report vaccine world research growing growth market
Vaccine research market size to grow at a CAGR of 9.88% from 2022 to 2027, Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, more to emerge as key players, Technavio
Published: 2024-03-11 (Crawled : 14:30) - prnewswire.com
CMXHF | $172.54 -1.41% -19.21% 50
|
n/a
|
| O: 0.41%
H: 0.0%
C: 0.0%
CSLLY | $87.96 0.15% 3.3% 45K
|
n/a
|
| O: -4.92%
H: 3.76%
C: 3.44%
GLAXF | $20.2 0.65% -14.18% 290
|
Health Technology
|
| O: -3.4%
H: 1.49%
C: 1.49%
AZNCF | $140.15 3.58% -4.19% 560
|
Health Technology
|
| O: 1.55%
H: 0.82%
C: 0.16%
ALPMY | News | $9.46 1.29% -1.11% 500K
|
Manufacturing
|
| O: -1.41%
H: 5.06%
C: 4.01%
GSK | $39.6 -0.88% 0.03% 2.6M
|
Health Technology
|
| O: -0.6%
H: 0.19%
C: 0.09%
ABT | News | $105.9 -3.03% 1.12% 11M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
AZN | $68.53 0.39% 0.39% 3.2M
|
Health Technology
|
| O: 1.08%
H: 0.82%
C: 0.67%
pharma vaccine astrazeneca research key market
Global Respiratory Disease Vaccine Market Set for Growth, Fueled by Aging Populations and Vaccine Mandates - Trends, Opportunities, and Forecasts, 2018-2028F
Published: 2024-01-22 (Crawled : 17:00) - prnewswire.com
SNYNF | News | $92.7 0.63% -2.18% 1.4K
|
Health Technology
|
| O: 1.71%
H: 0.0%
C: -0.15%
AZNCF | $140.15 3.58% -4.19% 560
|
Health Technology
|
| O: 2.63%
H: 0.8%
C: 0.75%
JNJ | News | $144.77 0.22% 0.22% 7.9M
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: 0.0%
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: -0.21%
H: 0.0%
C: 0.0%
AZN | $68.53 0.39% 0.39% 3.2M
|
Health Technology
|
| O: 1.8%
H: 0.14%
C: -0.89%
disease vaccine respiratory global set market
Fluzone High-Dose Quadrivalent vaccine remains preferentially recommended to protect adults 65 years of age and older against influenza
Published: 2024-01-03 (Crawled : 22:00) - biospace.com/
SNYNF | News | $92.7 0.63% -2.18% 1.4K
|
Health Technology
|
| O: 0.49%
H: 0.0%
C: -0.26%
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: 1.38%
H: 0.0%
C: 0.0%
vaccine influenza
BioNTech Achieves Milestone at mRNA-based Vaccine Manufacturing Site in Rwanda
Published: 2023-12-18 (Crawled : 18:00) - globenewswire.com
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: 0.45%
H: 0.0%
C: 0.0%
BNTX | $86.4 0.07% 0.09% 1.2M
|
Health Technology
|
| O: 0.9%
H: 2.47%
C: 2.11%
vaccine milestone
Influenza Vaccine Market to grow by USD 2.93 billion from 2022 to 2027; North America to account for 54% of market growth - Technavio
Published: 2023-12-13 (Crawled : 19:00) - prnewswire.com
CMXHF | $172.54 -1.41% -19.21% 50
|
n/a
|
| O: 5.56%
H: 0.71%
C: 0.71%
CSLLY | $87.96 0.15% 3.3% 45K
|
n/a
|
| O: 1.46%
H: 3.01%
C: 0.97%
GLAXF | $20.2 0.65% -14.18% 290
|
Health Technology
|
| O: 0.58%
H: 0.0%
C: -1.01%
SNYNF | News | $92.7 0.63% -2.18% 1.4K
|
Health Technology
|
| O: 0.25%
H: 0.0%
C: 0.0%
AZNCF | $140.15 3.58% -4.19% 560
|
Health Technology
|
| O: 1.19%
H: 3.09%
C: 1.3%
GSK | $39.6 -0.88% 0.03% 2.6M
|
Health Technology
|
| O: 0.76%
H: 1.0%
C: -0.11%
BAX | News | $39.52 -0.13% 0.0% 2.8M
|
Health Technology
|
| O: 1.7%
H: 2.44%
C: 1.78%
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
AZN | $68.53 0.39% 0.39% 3.2M
|
Health Technology
|
| O: 1.21%
H: 0.27%
C: -0.52%
america vaccine influenza growth market
GSK Pulls Ahead of Pfizer in RSV Vaccine Market as Arexvy Nears Blockbuster S...
Published: 2023-12-01 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 0.63% -2.18% 1.4K
|
Health Technology
|
| O: 1.39%
H: 0.0%
C: -0.05%
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: 0.93%
H: 0.0%
C: 0.0%
vaccine rsv market
GSK Pulls Ahead of Pfizer in RSV Vaccine Market as Arexvy Nears Blockbuster Status
Published: 2023-12-01 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 0.63% -2.18% 1.4K
|
Health Technology
|
| O: 1.39%
H: 0.0%
C: -0.05%
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: 0.93%
H: 0.0%
C: 0.0%
vaccine rsv market
Rabies Vaccine Market to Reach $ 1903.17 million by 2032, exhibiting a CAGR of 4.7% from 2023 to 2032: Allied Market Research
Published: 2023-11-25 (Crawled : 08:20) - prnewswire.com
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
| Email alert
Add to watchlist
ELAN | $13.41 -1.69% 0.0% 4.1M
|
Process Industries
| Email alert
Add to watchlist
SNYNF | News | $92.7 0.63% -2.18% 1.4K
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $93.08 -0.13% 0.13% 1.1M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
ZTS | News | $151.94 -0.71% 2.38% 3.3M
|
Health Technology
| Email alert
Add to watchlist
FNCTF | News | $11.0354 -0.83% -20.84% 34K
|
Communications
| Email alert
Add to watchlist
vaccine reach research market
HDT Bio to Participate in World Vaccine Congress West Coast 2023
Published: 2023-11-16 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 0.63% -2.18% 1.4K
|
Health Technology
|
| O: 3.37%
H: 1.29%
C: 1.29%
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: 1.54%
H: 0.0%
C: 0.0%
west vaccine congress world
Global HBV Vaccine Market Set to Reach $2.47 Billion by 2023, Driven by Rising HBV Cases Among Infants
Published: 2023-11-11 (Crawled : 04:20) - prnewswire.com
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
| Email alert
Add to watchlist
DVAX | $11.43 -0.52% -0.44% 2.5M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 0.63% -2.18% 1.4K
|
Health Technology
| Email alert
Add to watchlist
vaccine reach global set market
Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19
Published: 2023-10-26 (Crawled : 11:00) - globenewswire.com
PFE A | $25.42 -1.05% 0.16% 40M
|
Health Technology
|
| O: -0.39%
H: 2.48%
C: 1.8%
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: 0.09%
H: 0.0%
C: 0.0%
BNTX | $86.4 0.07% 0.09% 1.2M
|
Health Technology
|
| O: 0.99%
H: 1.81%
C: 0.47%
covid-19 vaccine positive influenza topline program
MinervaX Raises EUR 54M in Upsized Financing to Advance the Development of its Maternal Vaccine Against Group B Streptococcus
Published: 2023-10-11 (Crawled : 07:00) - prnewswire.com
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: 1.1%
H: 0.0%
C: 0.0%
vaccine group
Global Influenza Vaccine Market Research Report 2023-2028: Shift in Trends towards mRNA-based Flu Vaccine Gaining Momentum
Published: 2023-10-05 (Crawled : 23:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 290
|
Health Technology
|
| O: 0.5%
H: 0.0%
C: 0.0%
AZNCF | $140.15 3.58% -4.19% 560
|
Health Technology
|
| O: -0.48%
H: 1.63%
C: -0.57%
GSK | $39.6 -0.88% 0.03% 2.6M
|
Health Technology
|
| O: 0.94%
H: 0.82%
C: 0.41%
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: -0.19%
H: 0.0%
C: 0.0%
AZN | $68.53 0.39% 0.39% 3.2M
|
Health Technology
|
| O: 0.24%
H: 0.78%
C: 0.57%
report vaccine momentum influenza research global trends market
FDA Panel Sets Possible Precedent; Novavax Wins Approval for Updated COVID-19 Vaccine
Published: 2023-10-05 (Crawled : 15:30) - biospace.com/
PRGO | $30.04 0.27% 0.97% 650K
|
Health Technology
|
| O: 0.4%
H: 2.05%
C: 1.82%
JNJ | News | $144.77 0.22% 0.22% 7.9M
|
Health Technology
|
| O: 0.4%
H: 0.0%
C: 0.0%
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: 0.19%
H: 0.0%
C: 0.0%
covid-19 fda vaccine approval
Moderna Announces Positive Phase 1/2 Data from mRNA-1083, the Company's Combination Vaccine Against Influenza and COVID-19
Published: 2023-10-04 (Crawled : 12:00) - biospace.com/
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: 1.07%
H: 0.0%
C: 0.0%
MRNA | News S | $103.44 -0.34% -0.33% 1.5M
|
Health Technology
|
| O: 1.48%
H: 0.2%
C: -0.33%
rna-1083 covid-19 vaccine positive influenza
Press Release: Sanofi announces agreement for potential first-in-class vaccine against extraintestinal pathogenic E. coli
Published: 2023-10-03 (Crawled : 06:00) - globenewswire.com
JNJ | News | $144.77 0.22% 0.22% 7.9M
|
Health Technology
|
| O: -0.26%
H: 0.53%
C: 0.43%
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: -1.41%
H: 0.0%
C: 0.0%
vaccine potential agreement sanofi
Pfizer and BioNTech Receive Health Canada Authorization for XBB.1.5-Adapted Monovalent COVID-19 Vaccine
Published: 2023-09-28 (Crawled : 17:00) - globenewswire.com
SNYNF | News | $92.7 0.63% -2.18% 1.4K
|
Health Technology
|
| O: -2.28%
H: 0.0%
C: -0.06%
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: -1.61%
H: 0.0%
C: 0.0%
BNTX | $86.4 0.07% 0.09% 1.2M
|
Health Technology
|
| O: 0.21%
H: 0.04%
C: -1.27%
covid-19 vaccine health authorization canada
Gainers vs Losers
| 57% | 43% |
Top 10 Gainers
INVO | $1.82 139.47% 56.82% 220M
|
Health Technology
SINT | $0.0373 62.88% 37.26% 460M
|
Health Technology
WISA 4 | $9.25 51.64% 34.27% 64M
|
Electronic Technology
EDBL | News | $6.66 46.37% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 600K
|
Manufacturing
TCON | $2.29 33.92% 26.61% 1.8M
|
Health Technology
TIRX | $0.4848 7.49% 24.58% 5.9M
|
SRFM 4 | $0.3859 -12.3% 23.84% 660K
|
n/a
KZIA | $0.3442 18.28% 23.42% 290K
|
Health Technology
VNDA | News | $5.24 29.38% 22.56% 24M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.